The healthcare world is seeing a major shift in blood sugar management with the emergence of GLP-1 transdermal devices. These systems offer a potentially more comfortable alternative to injections of GLP-1 receptor agonists, lessening the need for daily needle pokes. The approach delivers the compound directly through the epidermis, potentially … Read More